{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:22:04Z","timestamp":1791908524334,"version":"4.3.4"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Miscarriage is a common and serious adverse pregnancy outcome. Assessing drug-associated miscarriage risk is essential for medication safety in pregnancy. Using the FDA Adverse Event Reporting System this study systematically mined adverse drug events related to miscarriage and combined machine learning with explainable Artificial Intelligence to evaluate potential high-risk drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrieved FAERS reports of miscarriage-associated ADEs from 2005 to 2024. Disproportionality analyses were conducted using the reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian Confidence Propagation Neural Network (BCPNN), and Multi-Item Gamma Poisson Shrinker (MGPS), with subgroup analyses by age and body weight. An eXtreme Gradient Boosting (XGBoost) model was developed to predict miscarriage risk, and Shapley Additive exPlanations (SHAP) were used to interpret feature contributions. Finally, Weibull distribution modeling characterized the time-to-onset (TTO) from drug exposure to miscarriage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 36,389 ADEs were included. We identified several potential high-risk classes, notably immunomodulators, psychoactive\/neuroactive agents, and antimicrobials. The XGBoost model showed favorable discrimination with a mean area under the curve (AUC) of 0.738. SHAP analysis reveals that immunomodulatory factors, such as adalimumab and infliximab, are significant predictors of miscarriage events in this model. The distribution of their SHAP values suggests a strong association between these drugs and miscarriage reports. time-to-onset analyses suggested that most miscarriages occurred within 2\u00a0years after drug exposure, with marked heterogeneity in risk timing across agents; anti-Tumor Necrosis Factor-alpha drugs (TNF-\u03b1) exhibited a higher early risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Machine learning and SHAP interpretability analysis based on the FAERS database effectively identified immunomodulators, antiviral drugs, and psychiatric\/neuropsychiatric medications as potential risk signals associated with miscarriage. These findings underscore the need for individualized medication assessment that considers patient age and body weight, providing evidence-based guidance and early alerting for reference for drug risk assessment during pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1687391","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:31:22Z","timestamp":1771828282000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk assessment of drug-associated miscarriage using XGBoost and SHAP explainability: a real-world pharmacovigilance analysis based on the FAERS database"],"prefix":"10.3389","volume":"17","author":[{"given":"Sen","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Oncology and Hematology, Shenzhen Traditional Chinese Medicine Hospital","place":["Shenzhen, China"]},{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanyue","family":"Ma","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Zhao","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Peng","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]},{"name":"Department of Hepatology, Shenzhen Municipal Hospital of Traditional Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfei","family":"Li","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Li","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Shenzhen Traditional Chinese Medicine Hospital","place":["Shenzhen, China"]},{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1097\/aog.0000000000002833","article-title":"No. 199: use of prophylactic antibiotics in labor and delivery","volume":"132","year":"2018","journal-title":"Obstetrics Gynecology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ajmg.c.30313","article-title":"Evolving knowledge of the teratogenicity of medications in human pregnancy","author":"Adam","year":"2011","journal-title":"Am. J. Med. Genetics Part C, Seminars Medical Genetics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1477-7827-10-49","article-title":"The effects of oxidative stress on female reproduction: a review","volume":"10","author":"Agarwal","year":"2012","journal-title":"Reproduct. Biol. Endocrinol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"E179","DOI":"10.1503\/cmaj.180963","article-title":"Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies","volume":"191","author":"B\u00e9rard","year":"2019","journal-title":"Can. Med. Assoc. J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/j.jaci.2021.02.037","article-title":"The safety of asthma medications during pregnancy and lactation: clinical management and research priorities","volume":"147","author":"Chambers","year":"2021","journal-title":"J. Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1145\/2939672.2939785","article-title":"XGBoost: a scalable tree boosting system. In","volume-title":"proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining","author":"Chen","year":"2016"},{"key":"B7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-3-030-53352-6_24","article-title":"Explaining models by propagating Shapley values of local components","volume":"914","author":"Chen","year":"2021","journal-title":"Explain AI Healthc. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF03256733","article-title":"Comparison of sensitivity and timing of early signal detection of four frequently used signal detection methods","volume":"22","author":"Chen","year":"2008","journal-title":"Pharm. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jad.2024.12.102","article-title":"Antipsychotic use during pregnancy and outcomes in pregnant individuals and newborns","volume":"373","author":"Cho","year":"2025","journal-title":"J. Affect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3390\/antiox13121518","article-title":"Oxidative stress induced by antivirals: implications for adverse outcomes during pregnancy and in newborns","volume":"13","author":"Costa","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1017\/erm.2022.18","article-title":"Tnf-\u0391\/anti-Tnf-\u0391 drugs and its effect on pregnancy outcomes","volume":"24","author":"Dai","year":"2022","journal-title":"Expert Rev. Mol. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","article-title":"Recurrent pregnancy loss","volume":"6","author":"Dimitriadis","year":"2020","journal-title":"Nat. Reviews Dis. Primers"},{"key":"B13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3233\/shti240533","article-title":"Causal deep learning for the detection of adverse drug reactions: drug-induced acute kidney injury as a case study","volume":"316","author":"Dimitsaki","year":"2024","journal-title":"Stud. Health Technolo. Informat."},{"key":"B14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (Prrs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol. Drug Safety"},{"key":"B15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41598-023-50669-1","article-title":"Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational embryotox cohort study","volume":"14","author":"Fietz","year":"2024","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/ijms26031295","article-title":"Exploring the immunological aspects and treatments of recurrent pregnancy loss and recurrent implantation failure","volume":"26","author":"Garmendia","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/biom11020253","article-title":"Role of vascular endothelial growth factor (Vegf) in human embryo implantation: clinical implications","volume":"11","author":"Guo","year":"2021","journal-title":"Biomolecules"},{"key":"B18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/epi.17800","article-title":"Antiepileptic treatment with levetiracetam during the first trimester and pregnancy outcome: an observational study","volume":"65","author":"Hoeltzenbein","year":"2024","journal-title":"Epilepsia"},{"key":"B19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/cid\/ciy471","article-title":"Adverse pregnancy outcomes among women who conceive on antiretroviral therapy","volume":"68","author":"Hoffman","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"m237","DOI":"10.1136\/bmj.m237","article-title":"Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study","volume":"368","author":"Huybrechts","year":"2020","journal-title":"BMJ Clin. Res. Ed"},{"key":"B21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/qad.0000000000002824","article-title":"Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women","volume":"35","author":"Ikumi","year":"2021","journal-title":"Aids"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1554875","DOI":"10.3389\/fmed.2025.1554875","article-title":"Research hotspots and trends in unexplained recurrent spontaneous abortion (Ursa) from 2014 to 2024: a bibliometric analysis","volume":"12","author":"Jiang","year":"2025","journal-title":"Front. Medicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaut.2016.11.004","article-title":"Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-\u0391 use in females with immune mediated diseases; a systematic review and meta-analysis","volume":"76","author":"Komaki","year":"2017","journal-title":"J. Autoimmu."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/humrep\/deh277","article-title":"Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study","volume":"19","author":"Lashen","year":"2004","journal-title":"Hum. Reproduct. Oxf. Engl."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/cpt.2172","article-title":"A new era in pharmacovigilance: toward real-world data and digital monitoring","volume":"109","author":"Lavertu","year":"2021","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.drudis.2019.03.003","article-title":"Machine learning on adverse drug reactions for pharmacovigilance","volume":"24","author":"Lee","year":"2019","journal-title":"Drug Dis. Today"},{"key":"B27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2165\/00002018-200023060-00004","article-title":"A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the who international database","volume":"23","author":"Lindquist","year":"2000","journal-title":"Drug Safety"},{"key":"B28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/s2213-8587(25)00127-5","article-title":"Parental preconception bmi and risk of adverse birth outcomes in 8 million parent-child triads: a nationwide population-based cohort study in China","volume":"13","author":"Liu","year":"2025","journal-title":"Lancet Diab. Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From local explanations to global understanding with explainable AI for trees","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat. Machine Intell."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e004365","DOI":"10.1136\/bmjopen-2013-004365","article-title":"Medication use in pregnancy: a cross-sectional, multinational web-based study","volume":"4","author":"Lupattelli","year":"2014","journal-title":"BMJ Open"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17113830","article-title":"Use and intentional avoidance of prescribed medications in pregnancy: a cross-sectional, web-based study among 926 women in Italy","volume":"17","author":"Lupattelli","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"l869","DOI":"10.1136\/bmj.l869","article-title":"Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study","volume":"364","author":"Magnus","year":"2019","journal-title":"BMJ Clin. Res. Ed"},{"key":"B33","doi-asserted-by":"publisher","first-page":"250.e1","DOI":"10.1016\/j.ajog.2023.12.020","article-title":"Prescription medication use during pregnancy in the United States from 2011 to 2020: trends and safety evidence","volume":"231","author":"Mansour","year":"2024","journal-title":"Am. J. Obstetr. Gynecol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2165\/00002018-200730080-00008","article-title":"Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer","volume":"30","author":"Matsushita","year":"2007","journal-title":"Drug Safety"},{"key":"B35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1365-2125.2011.04037.x","article-title":"Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database","volume":"72","author":"Montastruc","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1749-6632.2010.05938.x","article-title":"Inflammation and pregnancy: the role of the immune system at the implantation site","volume":"1221","author":"Mor","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"E625","DOI":"10.1503\/cmaj.161020","article-title":"Use of antibiotics during pregnancy and risk of spontaneous abortion","volume":"189","author":"Muanda","year":"2017","journal-title":"Can. Med. Assoc. J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1528-1157.1980.tb04320.x","article-title":"Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a Collaborative Study Group in Japan","volume":"21","author":"Nakane","year":"1980","journal-title":"Epilepsia"},{"key":"B39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/COH.0b013e3283632b88","article-title":"Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child","volume":"8","author":"Newell","year":"2013","journal-title":"Curr. Opinion HIV AIDS"},{"key":"B40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/phar.70010","article-title":"A review of antibiotic safety in pregnancy-2025 update","volume":"45","author":"Nguyen","year":"2025","journal-title":"Pharmacotherapy"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod. Toxicol. (Elmsford, NY)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/ijms25010390","article-title":"Valproic acid in pregnancy revisited: neurobehavioral, biochemical and molecular changes affecting the embryo and fetus in humans and in animals: a narrative review","volume":"25","author":"Ornoy","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/pharmaceutics14020266","article-title":"Using machine learning for pharmacovigilance: a systematic review","volume":"14","author":"Pilipiec","year":"2022","journal-title":"Pharmaceutics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/s0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet (London, Engl.)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e034529","DOI":"10.1136\/bmjopen-2019-034529","article-title":"Differences in medication beliefs between pregnant women using medication, or not, for chronic diseases: a cross-sectional, multinational, web-based study","volume":"10","author":"Roldan Munoz","year":"2020","journal-title":"BMJ Open"},{"key":"B46","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiol. Drug Safety"},{"key":"B47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12884-025-07144-8","article-title":"Prevalence, risk factors, and adverse outcomes of bacterial vaginosis among pregnant women: a systematic review","volume":"25","author":"Sethi","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"key":"B48","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1053\/beog.2001.0241","article-title":"Drugs in pregnancy. Drugs to avoid","volume":"15","author":"Shehata","year":"2001","journal-title":"Best Pract. Res. Clin. Obstetr. Gynaecol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"110024","DOI":"10.1016\/j.yebeh.2024.110024","article-title":"Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: data from the eurap neurocognitive extension protocol","volume":"159","author":"Stjerna","year":"2024","journal-title":"Epilepsy Behav."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/0895-4356(92)90158-j","article-title":"Serum sickness-like reactions to cefaclor","volume":"45","author":"Stricker","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA\u2019s spontaneous reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Safety"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1093\/cid\/ciaa805","article-title":"Pregnancy outcomes of women conceiving on antiretroviral therapy (Art) compared to those commenced on art during pregnancy","volume":"73","author":"Theron","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3390\/nu16111556","article-title":"Implications of prenatal exposure to endocrine-disrupting chemicals in offspring development: a narrative review","volume":"16","author":"Toledano","year":"2024","journal-title":"Nutrients"},{"key":"B54","doi-asserted-by":"publisher","first-page":"347.e1","DOI":"10.1016\/j.ajog.2019.05.034","article-title":"Miscarriage among women in the United States women\u2019s interagency HIV study, 1994\u20132017","volume":"221","author":"Wall","year":"2019","journal-title":"Am. J. Obstetr. Gynecol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1186\/s12889-025-22716-1","article-title":"Long-term trends in the global burden of maternal abortion and miscarriage from 1990 to 2021: joinpoint regression and age-period-cohort analysis","volume":"25","author":"Wang","year":"","journal-title":"BMC Public Health"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1007\/s12072-025-10783-w","article-title":"Analysis of risk factors for immune checkpoint inhibitor-associated liver injury: a retrospective analysis based on clinical study and real-world data","volume":"19","author":"Wang","year":"","journal-title":"Hepatol. Int."},{"key":"B57","doi-asserted-by":"publisher","first-page":"C1941","DOI":"10.1152\/ajpcell.00563.2024","article-title":"Itga3 participates in the pathogenesis of recurrent spontaneous abortion by downregulating Ulk1-Mediated autophagy to inhibiting trophoblast function","volume":"328","author":"Wang","year":"","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40263-024-01131-x","article-title":"Comparative safety of antipsychotic medications and mood stabilizers during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes","volume":"39","author":"Wang","year":"","journal-title":"CNS Drugs"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1109\/jbhi.2025.3561197","article-title":"Integrating transformer and graph attention network for Circrna-Mirna interaction prediction","volume":"29","author":"Wei","year":"2025","journal-title":"IEEE J. Biomed. Health Inf."},{"key":"B60","doi-asserted-by":"publisher","first-page":"112078","DOI":"10.1016\/j.patcog.2025.112078","article-title":"Multi-Hop graph structural modeling for cancer-related Circrna-Mirna interaction prediction","volume":"170","author":"Wei","year":"2026","journal-title":"Pattern Recognit."},{"key":"B61","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/cpt.2981","article-title":"Patterns of prescription medication use during the first trimester of pregnancy in the United States, 1997-2018","volume":"114","author":"Werler","year":"2023","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1101\/2024.08.04.24311480","article-title":"Foundational model aided automatic high-throughput drug screening using self-controlled cohort study","author":"Xu","year":"2024","journal-title":"medRxiv"},{"key":"B63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/ijms24010132","article-title":"The update immune-regulatory role of Pro- and anti-inflammatory cytokines in recurrent pregnancy losses","volume":"24","author":"Yang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJMoa1905230","article-title":"Neural-tube defects and antiretroviral treatment regimens in Botswana","volume":"381","author":"Zash","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1687391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:31:23Z","timestamp":1771828283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1687391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":64,"alternative-id":["10.3389\/fphar.2026.1687391"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1687391","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"article-number":"1687391"}}